TABLE OF CONTENTS

Volume 21, Issue 2

ACNR is a UK-based, international, open access, peer reviewed neurology journal which aims to keep busy practicing specialists up-to-date with the latest advances in their fields.

ISSN 1473-9348


Clinical Review Articles
  • Confidence College – an online education tool for neurology patients
  • Heather Angus-Leppan, Alice Caulfield, Melika M Moghim, Jennifer Nightingale, Rob Sloan, Tom Stables, Michael Oates, Bernadette Porter, Anette Schrag
Movement Disorders
  • Physical activity and exercise for people with Parkinson’s
  • Julie Jones, Katherine Baker, Bhanu Ramaswamy
Epilepsy Series
  • The Comorbidities of Epilepsy: Introduction
  • Marco Mula
  • Seizures and sleep: Not such strange bedfellows
  • Guy Leschziner
Sleep Series
  • Psychostimulants as cognitive enhancers – the evidence for the use and abuse of smart drugs
  • Poppy Goldsmith and Kirstie Anderson
Headache Series
  • Vestibular migraine
  • Nitesh Patel, Kulvinder Talewar, Anish Bahra, Diego Kaski
Special Features
  • Rehabilitating Romberg
  • Mark R Baker, Timothy L Williams, Andrew Larner
  • Arnold’s Nerve
  • JMS Pearce

Related

  • HOME
  • ISSUES
  • EXPLORE CONTENT
    • Introduction
    • Articles
    • Book Reviews
    • Case Reports
    • News
    • Sponsored Editorial
  • EVENTS
    • Introduction
    • Event News
    • Conference Reports
    • Submit your event to ACNR
  • AUTHORS
    • Introduction
    • Author Guidelines
    • Author Disclosure
  • RESOURCES
  • ABOUT
    • Introduction
    • How is ACNR funded?
    • Editorial Board
    • Peer Reviewers
    • Policies and Forms
    • Ethics and Malpractice
    • Email Newsletter
    • Mail Signup
    • ACNR Privacy Policy
This website is intended for healthcare professionals
ACNR
  • HOME
  • ISSUES
  • EXPLORE CONTENT
    • Introduction
    • Articles
    • Book Reviews
    • Case Reports
    • News
    • Sponsored Editorial
  • EVENTS
    • Introduction
    • Event News
    • Conference Reports
    • Submit your Event to ACNR
  • AUTHORS
    • Introduction
    • Author Guidelines
    • Author Disclosure
  • RESOURCES
  • ABOUT
    • Introduction
    • How is ACNR Funded?
    • Editorial Board
    • Peer Reviewers
    • Policies and Forms
    • Ethics and Malpractice
    • Email Newsletter
    • Mail Signup
    • ACNR Privacy Policy
  • Menu

ACNR ARTICLES

Pellagra: 4 D’s and 8 Points

Author

  • Adrian Williams
  • MD MSc
  • Professor of Neurology

Adrian Williams is Professor of Neurology in Birmingham, UK. He has a long-standing interest in Nicotinamide metabolism originally in the context of Parkinson’s disease proposing that nicotinamide is a “double edged sword” with toxicity at either end of the dosage range. Later after a MSc sabbatical, he proposed that a higher nicotinamide dietary dose from eating more meat had been an important part of our evolution with a buffer from symbionts in the gut microbiome or more surprisingly TB that excrete nicotinic acid. Such microorganisms when relied upon too heavily can become dysbiotic causing diarrhoea and clinical tuberculosis.

Correspondence Address:
Adrian Williams, Department of Neurology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, B15 2TH, UK.

  • Correspondence Email:
  • adrian.williams1949@gmail.com

Conflict of Interest Statement:
None declared

Provenance and Peer Review:
Submitted and externally reviewed

Publication Dates:

Date First Submitted:
18 Aug 2020

Date Submitted after Peer Review:
12 Oct 2020

Acceptance Date:
13 Oct 2020

Publication Date:
04 Nov 2020

To cite:
https://doi.org/10.47795/FBFD9966

Licence:
Creative Commons license


Article Categories

  • ABN (5)
  • ABNT (7)
  • Alzheimer's Disease (3)
  • Australia/NewZealand (32)
  • Clinical Review (124)
  • COVID-19 (15)
  • Dementia (7)
  • Epilepsy (9)
  • Headache (4)
  • History (29)
  • Movement Disorders (3)
  • Multiple Sclerosis (16)
  • Neurological Literature (3)
  • Neurological Signs (2)
  • Neurosurgery (18)
  • Nutrition (5)
  • Pain (3)
  • Parkinson's Disease (28)
  • Personal Perspectives (2)
  • Rehabilitation (35)
  • Sleep (14)
  • Special Feature (45)
  • Stroke (11)
  • Supplements (1)

Abstract

Pellagra has largely been forgotten. This is unfortunate as important lessons are to be learnt for the diseases and social consequences of poverty (and of affluence) that often involve dietary nicotinamide and nicotinamide adenine dinucleotide (NAD) homeostasis. NAD disruption can occur not only from poor diet but from increased consumption of NAD from genotoxic and other stresses. High doses of nicotinamide lead to inhibition of NAD-consuming enzymes and excessive induction of nicotinamide-n-methyl transferase (NNMT) with consequent effects on the methylome giving a mechanism for a new hypervitaminosis-B3.


Introduction

The history of Pellagra has been largely forgotten even if the 4 ‘D’s’ of Dementia, Dermatitis, Diarrhoea and Death are still taught to medical students.1, 2

Few realise that a festinating gait, fasciculation of the tongue or myoclonic encephalopathy were first described in the pellagra epidemics and other close mimics of many neurodegenerative and neuropsychiatric diseases were seen.

Pellagrins were prone to both dysbiotic and acute infections explaining the gut manifestations and the high incidence of TB.  It was widely believed to be hereditary and certainly ran in families.

comorbidities of epilepsy

The original 18thC European epidemics affected poor peasants on monophagic maize based polenta diets. The early 20th C American epidemic predominantly affected poor blacks (and whites) often working as semi-slave sharecroppers thrown into poverty with the collapse of the cotton market and eating maize, molasses and small quantities of low quality pork.

Pellagra was believed to be degenerative in the dehumanising and atavistic sense of the term. Homo sapiens evolved on a high meat high nicotinamide diet so pellagra can now be seen as an example of human evolution in reverse.  Inferior cognition and antisocial and addictive behaviours led to discrimination as the degenerate “Butterfly caste” contrasting with most societies that have ruling “meat elites”. Pellagrins were seen as a different race having a different physiognomy that crossed colour lines even though it was, as it turned out, an archetypal disease of poverty, rather like TB. Pellagrins were at times subject to and used as an exemplar to justify eugenic thinking.

 Pellagra was a systems failure causing premature ageing with evidence of mitochondrial failure, oxidative stress and proteinopathy. Pellagra was curable particularly after the discovery of nicotinamide in the 1940s and is normally sourced from animal products as Vitamin B3. There were many undiagnosed and untreated cases as the exaggerated sunburn rash (Casal’s necklace) was often not present (“pellagra sine pellagra”) particularly in those with pigmented skin.

Point 1.  A disorder that mimicked many neurodegenerative conditions as now classified can have a single and simple dietary cause even when there is evidence for (epi-) genetic involvement, dysbiotic microbiomes, mitochondrial and oxidative stress, and proteinopathy.  Dietary nicotinamide with back-up from the degradation of tryptophan on the kynurenine pathway are the precursors to NAD critical to mitochondrial energetics as NADH (and other dehydrogenase reactions), anabolism as NADP(H), and NAD consumer pathways in an “NAD” world.3 Stress from toxins, whether chemical or microbial, requiring DNA or tissue repair by NAD consuming enzymes such as poly ADP ribose polymerases (PARPs) and Sirtuins could have the same pathological result if the dose of nicotinamide is not increased.

Point 2. Pellagra may be being missed. The better known clinical manifestations were recognised as being the “tip of the iceberg” in the epidemics in Europe and the south-eastern confederate states of the USA. Pellagra may be endemic in the millions in poverty who are meat and milk deprived masquerading as Kwashiorkor (“juvenile pellagra”) or “environmental enteropathy” or as poor cognition particularly in black populations who are resistant to the sunburn rash. A community screening test that would not be difficult to develop should be a priority.4

Point 3.  Tuberculosis (TB), dysbiotic diarrhoeal illnesses and high death rates from acute infections, such as smallpox and measles, disappear as societies increase their meat and nicotinamide intake. This is no mystery as nicotinamide and its analogues, such as Isoniazid, are TB antibiotics and many bacterial toxins interact with NAD-consumer pathways – so being NAD replete would improve host resistance.5,6  Topically, COVID-19 interferes with the tryptophan uptake pathway and therefore NAD levels and T cell and Interferon responses through the Angiotensin-converting enzyme (ACE2) receptor through which it enters cells (that also malfunctions with mutations that lead to Hartnup disease that includes a pellagra-like syndrome). Some clinical manifestations, such as on gut and on cognition or long Covid, could be “formes fruste” or new versions of pellagra.7

Point 4. Reduction in many infections coincided with “meat transitions” and triggered demographic and epidemiological switches toward infertility and auto-immune, allergic and other diseases of modernity. Immune intolerance with changes in T cell subset ratios come about from less use of Indoleamine 2,3-dioxygenase (IDO) and the tryptophan to kynurenine “immune tolerance” pathway as in house production of nicotinamide is no longer necessary.8 Dietary modification of nicotinamide or tryptophan in diet, perhaps in concert with other vitamins such as Vitamin D, could affect the incidence of auto-immune conditions such as Multiple Sclerosis.9

Point 5. Meat transitions and “modernity” have , as if by magic, reduced the incidence of premature ageing, dementia, and death. Stunted lives were features of pellagra and in all species there are well described links between NAD metabolism, stem cell health and ageing, alongside resistance to infection, so no magic or much medicine is required. NAD levels fall with age and even further with many diseases of ageing and could respond to supplementation.10-12

Point 6. Early pellagra-ologists, such as Lombroso, may have been right in sensing that pellagrins were atavistic examples of degeneration in the 19th century  sense of the term given that increasing meat intake was an important step in our evolution. For most of our evolution as hunter-gatherers we shared meat so the non-egalitarian  meat variances that later developed are surprising and are now extreme with 100 fold variances across the globe between rich and poor. As a result, the poor particularly in poor countries face an adverse metabolic and transgenerational NAD headwind.13

Point 7. Inequalities of meat intake between classes and countries need to be fairer.  Such extremes can be traced back to 17th century common pastureland “enclosure” movements and 19th century colonialism with the creation of the “third world” both channelling meat to the wealthy.  Earlier extremes between the Old World and the New World that had few natural animal domesticates were corrected by the Columbian exchange enabling the rise of the West.  However the global South was also unlucky in its meat supply, particularly Africa with a lack of animal domesticates and unhelpful human and veterinary infections in the tsetse fly belt with trypanosomiasis and rinderpest. Darker skin colour reduces the diagnostic help from sunburn and is a mixed blessing if it is acting as a warning of the more serious effects of nicotinamide deficiency compounding the problem. 4

Point 8.  There may be a state of hypervitaminosis-B3. Many conditions, such as some cancers and metabolic syndromes common with affluence and a high meat intake (let alone nicotinamide supplementation) are linked to induction of the enzyme NNMT. NNMT detoxifies nicotinamide but consumes valuable methyl groups and nicotinamide overload might over-inhibit NAD-consumer enzymes that are metabolic master molecules.14-16  Nicotinamide’s methylated derivative resembles the dopaminergic neurotoxin MPTP and may, like nicotinamide, be a “double-edged sword”.

Conclusion

Pellagra’s history is well worth remembering given that nobody systematically makes sure that it or “pellagra sine pellagra” is eliminated. Many in poverty remain at risk given that variances of meat intake are now historically extreme across countries and classes.  Multi-organ pellagra was never “owned” by any one specialty but it should have remained a public health concern doubtless helped by supplementation but not helped by never being a universal policy. Nicotinamide’s potential toxicity in high meat economies was also never monitored over the long-term.

Dietary dosage or nicotinamide supplements may need to be boosted when individuals have certain mutations or are under stress, whether genotoxic or anoxic/metabolic – or restrained if there really is a hypervitaminosis B3 contributing to diseases of affluence. The environmental cost of optimising meat intake would be mitigated by affluent countries eating and wasting less but sharing more. The meat supply needs to be safe, with the poor not having to rely on “bush meat” or “wet markets” so as not to risk food poisoning or old and new zoonoses, such as COVID-19. Supplementation of nicotinamide alone may not be enough as animal products contain other helpful micronutrients such as iron and sources of methyl-groups such as choline and vitamin B12.


References

  1. Rajakumar K. Pellagra in the United States: a historical perspective. Southern medical journal. 2000;93(3):272-7. https://doi.org/10.1097/00007611-200003000-000052
  2. Williams AC, Ramsden DB. Pellagra: A clue as to why energy failure causes diseases? Medical hypotheses. 2007;69(3):618-28. https://doi.org/10.1016/j.mehy.2007.01.029
  3. Imai S. The NAD World: a new systemic regulatory network for metabolism and aging–Sirt1, systemic NAD biosynthesis, and their importance. Cell biochemistry and biophysics. 2009;53(2):65-74. https://doi.org/10.1007/s12013-008-9041-4
  4. Williams AC, Hill LJ. The 4 D’s of Pellagra and Progress. International journal of tryptophan research : IJTR. 2020;13:1178646920910159. https://doi.org/10.1177/1178646920910159
  5. Pajuelo D, Gonzalez-Juarbe N, Tak U, Sun J, Orihuela CJ, Niederweis M. NAD(+) Depletion Triggers Macrophage Necroptosis, a Cell Death Pathway Exploited by Mycobacterium tuberculosis. Cell reports. 2018;24(2):429-40. https://doi.org/10.1016/j.celrep.2018.06.042
  6. Deng Q, Barbieri JT. Molecular mechanisms of the cytotoxicity of ADP-ribosylating toxins. Annual review of microbiology. 2008;62:271-88. https://doi.org/10.1146/annurev.micro.62.081307.162848
  7. Baig AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms. ACS chemical neuroscience. 2020;11(7):995-8. https://doi.org/10.1021/acschemneuro.0c00122
  8. Williams AC, Hill LJ. Nicotinamide and Demographic and Disease transitions: Moderation is Best. International journal of tryptophan research : IJTR. 2019;12:1178646919855940. https://doi.org/10.1177/1178646919855940
  9. Sonner JK, Keil M, Falk-Paulsen M, Mishra N, Rehman A, Kramer M, et al. Dietary tryptophan links encephalogenicity of autoreactive T cells with gut microbial ecology. Nature communications. 2019;10(1):4877. https://doi.org/10.1038/s41467-019-12776-4
  10. McReynolds MR, Chellappa K, Baur JA. Age-related NAD(+) decline. Experimental gerontology. 2020;134:110888. https://doi.org/10.1016/j.exger.2020.110888
  11. Rajman L, Chwalek K, Sinclair DA. Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence. Cell metabolism. 2018;27(3):529-47. https://doi.org/10.1016/j.cmet.2018.02.011
  12. Zhang M, Ying W. NAD(+) Deficiency Is a Common Central Pathological Factor of a Number of Diseases and Aging: Mechanisms and Therapeutic Implications. Antioxidants & redox signaling. 2019;30(6):890-905. https://doi.org/10.1089/ars.2017.7445
  13. Williams AC, Hill LJ. Nicotinamide as Independent Variable for Intelligence, Fertility, and Health: Origin of Human Creative Explosions? International journal of tryptophan research : IJTR. 2019;12:1178646919855944. https://doi.org/10.1177/1178646919855944
  14. Pissios P. Nicotinamide N-Methyltransferase: More Than a Vitamin B3 Clearance Enzyme. Trends in endocrinology and metabolism: TEM. 2017;28(5):340-53. https://doi.org/10.1016/j.tem.2017.02.004
  15. Schmeisser K, Parker JA. Nicotinamide-N-methyltransferase controls behavior, neurodegeneration and lifespan by regulating neuronal autophagy. PLoS genetics. 2018;14(9):e1007561. https://doi.org/10.1371/journal.pgen.1007561
  16. Williams A, Ramsden D. Nicotinamide: a double edged sword. Parkinsonism & related disorders. 2005;11(7):413-20. https://doi.org/10.1016/j.parkreldis.2005.05.011

Related

Tags: ACE2, ageing, Covid-19, Meat transitions, Nicotinamide, tuberculosis

  • Published by Whitehouse Publishing
  • The Lynch, Mere, Wiltshire BA12 6DQ, United Kingdom
  • info@acnr.co.uk
  • +44 1747 860168

FOLLOW US

  • Facebook
  • Instagram
  • Twitter
  • Linkedin

ACNR SIGNUPS

Join our email list to be notified when there is new content or upcoming events. For UK-based specialists join our mailing list for the journal.

© 2022 ACNR. Published by Whitehouse Publishing. Read our Privacy and Cookie Policy. Website by Sugar Web.

SIGN UP FOR OUR EMAILING LIST

Sign up to receive our email newsletter with links to the latest content. ACNR is free, thanks to the support of advertisers. The editorial content is peer reviewed and remains completely independent unless clearly specified.

For UK-based specialists, sign up for our journal mailing list.